Sponsors today need faster decisions, cleaner insights, and real-time visibility across countries, vendors, and sites. Trial data can no longer sit at the back end; it must be decision-ready from first patient in through submission.
At Novotech, we create integrated trial data environments that give sponsors and sites a single source of truth. Role-based dashboards highlight study health and KPIs, while controlled access ensures quick, auditable queries. Platforms integrate EDC, eCOA/ePRO, labs, sensors, and operational metrics into clear, usable workflows. With predefined triggers and proactive monitoring, risks are surfaced early so teams can act while intervention is still possible.
In the latest issue of International Clinical Trials, David Ng, Vice President of Global Biometrics at Novotech, outlines what sponsors should expect from a data-driven CRO in 2025:
- Continuous data access
- End-to-end visibility
- Collaborative operating models
- Data management as a continuous service that enables adaptive designs and faster decisions